SPL 3.00% 9.7¢ starpharma holdings limited

Monkey Pox Virus, page-8

  1. 9,387 Posts.
    lightbulb Created with Sketch. 871
    Just doing a search Saudi starts approval from the standpoint of how it is aproval in a reference market - usually USA , Europe, Australia Japan and Canada . Things may have been delayed with no home market registration . i am not sure it it is a Saudi requirement) or a conflict in lodgement classification between markets ? .

    All sites show differening timeframes and slight differences in classification examples..

    Website pharma knowledge
    https://pharmaknowl.com/sfda-medical-devices-registration-saudi-arabia/


    Wish I knew more or SPL provided some more direction in relation to this matter and possible timeframes? .

    A search on SFDA website provides no information?

    https://www.sfda.gov.sa/en/solr-search/content?keys=viraleze
    https://www.sfda.gov.sa/en/solr-search/content?keys=SPL7013&type=All
    https://www.sfda.gov.sa/en/solr-search/content?keys=starpharma&type=All


    From one of the represenatives websites

    https://arazygroup.com/medical-device-registration-saudi-arabia/

    Last updated on November 17th, 2021.

    Medical Device Regulations and Classification in Saudi Arabia

    REGULATORY AUTHORITY: Saudi Food and Drug Authority (SFDA)

    CLASSIFICATION SYSTEM:

    After July 1, 2021, both medical devices and IVDs will follow this risk classification system:

    • Class A
    • Class B
    • Class C
    • Class D

    TIMEFRAME:

    Official Timeline

    Medical Device Marketing Authorization (MDMA): 35 working days

    Medical Device Listing in Medical Device National Registry (MDNR) – 4 working days (Class A); 10 working days (for Class B, C, D)

    Actual Timeline – (based on experience)

    Medical Device Marketing Authorization (MDMA): up to 2 months

    Medical Device Listing in Medical Device National Registry (MDNR): up to 2 weeks

    SPECIAL REQUIREMENTS:

    Local testing is required for devices that are listed in Annex 1 of MDS G29. In most cases, however, the application is waived from local testing.

    LOCAL FEES (New Application):

    Medical Device Marketing Authorization (MDMA):

    Class I/General IVDs/Exempt IVD (TGA) – USD 4000

    Class II/IIa/Self-test IVD/Listable IVD – USD 5067

    Class IIb/Class III (CA, PAL)/Annex II List B (IVD) – USD 5600

    Class III/Class IV/AIMD/Annex II List A (IVD)/Registrable IVD – USD 6133

    Medical Device Listing in Medical Device National Registry (MDNR): USD 135

    *Please note that these are fees currently enforced. However, as soon as the new regulation is enforced in January 2021, the new fee schedule will be implemented.

    LOCAL FEES (Manufacturer):

    Establishment License

    Prior to place medical devices on the market, any organization dealing with the importation and/or distribution shall apply for the Medical Device Establishment License (MDEL). The fees required varies (from USD 4000 to 9350) depending on type of medical devices they are dealing with.

    License for Authorized Representative (AR)

    The AR shall have separate licenses for each manufacturer it represents within the KSA. The fee required is fixed (around 1300 USD per year).

    LICENSE VALIDITY:

    MDMA certificate has a validity maximum 3 years. After July 1, 2021, the certificate will have a 3-years validity (consistently).

    The validity of License for AR varies depending on the agreement between the manufacturer and the AR.

    LICENSE TRANSFER: License transfers are possible in Saudi Arabia.

    AUTHORIZED REPRESENTATIVE/LICENSE HOLDER: Foreign manufacturer must appoint a company residing within the KSA to act on their behalf for specified tasks including dealing with the SFDA.

    ADDITIONAL INFORMATION: After July 1, 2021, risk classification system and new marketing authorization request via GHTF route is no longer accepted.

 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.